Syros to Participate in TD Cowen 44th Annual Health Care Conference
February 27 2024 - 7:00AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that its
Chief Executive Officer, Conley Chee, will participate in a panel
discussion at the TD Cowen 44th Annual Health Care Conference.
Management will also be available for one-on-one meetings. Details
are as follows:
TD Cowen 44th Annual Health Care Conference
Date: Tuesday, March 5 Panel Title: Novel Oncology Targets Panel
Time: 9:10 a.m. ET Location: Boston Marriott Copley Place, Boston,
MA
A live webcast of the panel discussion will be available on the
Investors & Media section of the Syros website at
www.syros.com. An archived replay of the webcast will be available
for approximately 30 days following the live event.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the
frontline treatment of patients with hematologic malignancies.
Driven by the motivation to help patients with blood disorders that
have largely eluded other targeted approaches, Syros is developing
tamibarotene, an oral selective RARα agonist in frontline patients
with higher-risk myelodysplastic syndrome and acute myeloid
leukemia with RARA gene overexpression. For more information, visit
www.syros.com and follow us on Twitter (@SyrosPharma) and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227887206/en/
Syros Contact Karen Hunady Director of Corporate
Communications & Investor Relations 1-857-327-7321
khunady@syros.com Investor Contact Hannah Deresiewicz Stern
Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Aug 2023 to Aug 2024